Niosomes (the nonionic surfactant vesicles), considered as novel drug delivery systems, can
improve the solubility and stability of natural pharmaceutical molecules. They are …

Introduction: The blood–brain barrier (BBB) represents a stringent barrier for delivery of
neurotherapeutics in vivo. An attempt to overcome this barrier is represented by the direct …

Although the global prevalence of neurological disorders such as Parkinson's disease,
Alzheimer's disease, glioblastoma, epilepsy, and multiple sclerosis is steadily increasing …

One of the major reasons why depressed patients fail their treatment course is the existence
of the blood-brain barrier (BBB), which prevents drugs from being delivered to the central …

Microemulsions are isotropic, thermodynamically stable transparent (or translucent) systems
of oil, water and surfactant, frequently in combination with a cosurfactant with a droplet size …

Nanoparticles can be administered via nasal, oral, intraocular, intratracheal (pulmonary
toxicity), tail vein and other routes. Here, we focus on the time-dependent translocation and …

The aim of the present study was to optimize lorazepam loaded PLGA nanoparticles (Lzp‐
PLGA‐NPs) by investigating the effect of process variables on the response using Box …

Epileptic seizure emergencies are life-threatening conditions, which in their most severe
form, status epilepticus, have a high mortality rate if not quickly terminated. Treatment …

The application of nanorobots to the human brain is denoted as “neuralnanorobotics.” This
technology may allow for the monitoring, recording, and even manipulation of many types of …

Since the discovery of microemulsions by Jack H. Shulman, there have been huge
progresses made in applying microemulsion syst ems in a plethora of research and …